Harnessing Machine Learning to Improve Healthcare Monitoring with FAERS
Keywords:
Machine Learning, Healthcare Monitoring, FDA Adverse Event Reporting System, FAERS, Pharmacovigilance Triage, Human ExpertiseAbstract
This research study investigates the potential of machine learning techniques to improve healthcare monitoring through the utilization of data from the FDA Adverse Event Reporting System (FAERS). The objective is to explore specific applications of machine learning in healthcare monitoring with FAERS and highlight their findings. The study reveals several significant ways in which machine learning can contribute to enhancing healthcare monitoring using FAERS.Machine learning algorithms can detect potential safety signals at an early stage by analyzing FAERS data. By employing anomaly detection and temporal pattern analysis techniques, these models can identify emerging safety concerns that were previously unknown or underreported. This early detection enables timely action to mitigate risks associated with medications or medical products.Machine learning models can assist in pharmacovigilance triage, addressing the challenge posed by the large number of adverse event reports within FAERS. By developing ranking and classification models, adverse events can be prioritized based on severity, novelty, or potential impact. This automation of the triage process enables pharmacovigilance teams to efficiently identify and investigate critical safety concerns.Machine learning models can automate the classification and coding of adverse events, which are often present in unstructured text within FAERS reports. Through the application of Natural Language Processing (NLP) techniques, such as named entity recognition and text classification, relevant information can be extracted, enhancing the efficiency and accuracy of adverse event coding.Machine learning algorithms can refine and validate signals generated from FAERS data by incorporating additional data sources, such as electronic health records, social media, or clinical trials data. This integration provides a more comprehensive understanding of potential risks and helps filter out false positives, facilitating the identification of signals requiring further investigation.Machine learning enables real-time surveillance of FAERS data, allowing for the identification of safety concerns as they occur. Continuous monitoring and real-time analysis of incoming reports enable machine learning models to trigger alerts or notifications to relevant stakeholders, promoting timely intervention to minimize patient harm.The study demonstrates the use of machine learning models to conduct comparative safety analyses by combining FAERS data with other healthcare databases. These models assist in identifying safety differences between medications, patient populations, or dosing regimens, enabling healthcare providers and regulators to make informed decisions regarding treatment choices.While machine learning is a powerful tool in healthcare monitoring, its implementation should be complemented by human expertise and domain knowledge. The interpretation and validation of results generated by machine learning models necessitate the involvement of healthcare professionals and pharmacovigilance experts to ensure accurate and meaningful insights.This research study illustrates the diverse applications of machine learning in improving healthcare monitoring using FAERS data. The findings highlight the potential of machine learning in early safety signal detection, pharmacovigilance triage, adverse event classification and coding, signal refinement and validation, real-time surveillance and alerting, and comparative safety analysis. The study emphasizes the importance of combining machine learning with human expertise to achieve effective and reliable healthcare monitoring.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Applied Research in Artificial Intelligence and Cloud Computing
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.